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Abstract: Esculetin (ESC) is a coumarin that is present in several plants such as Fraxinus 
rhynchophylla and Artemisia capillaris. Our previous study found that FR ethanol extract 
(FREtOH)  significantly  ameliorated  rats’  liver  function.  This  study  was  intended  to 
investigate the protective mechanism of ESC in hepatic apoptosis in rats induced by carbon 
tetrachloride. Rat hepatic apoptosis was induced by oral administration of CCl4. All rats 
were administered orally with CCl4 (20%, 0.5 mL/rat) twice a week for 8 weeks. Rats in 
the ESC groups were treated daily with ESC, and silymarin group were treated daily with 
silymarin.  Serum  alanine  aminotransferase  (ALT),  aspartate  aminotransferase  (AST)  as 
well  as  the  activities  of  the  anti-oxidative  enzymes  glutathione  peroxidase  (GPx), 
superoxide  dismutase  (SOD),  and  catalase  in  the  liver  were  measured.  In  addition, 
expression of liver apoptosis proteins and anti-apoptotic proteins were detected. ESC (100, 
500 mg/kg) significantly reduced the elevated activities of serum ALT and AST caused by 
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CCl4 and significantly increased the activities of catalase, GPx and SOD. Furthermore, 
ESC  (100,  500  mg/kg)  significantly  decreased  the  levels  of  the  proapoptotic  proteins  
(t-Bid, Bak and Bad) and significantly increased the levels of the anti-apoptotic proteins 
(Bcl-2  and  Bcl-xL).  ESC  inhibited  the  release  of  cytochrome  c  from  mitochondria.  In 
addition,  the  levels  of  activated  caspase-9  and  activated  caspase-3  were  significantly 
decreased  in  rats  treated  with  ESC  than  those  in  rats  treated  with  CCl4  alone.  ESC 
significantly reduced CCl4-induced hepatic apoptosis in rats. 
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1. Introduction 
Although many chronic viral hepatitis patients have been treated with interferon, the results of the 
therapy have not always been satisfactory. Chronic viral hepatitis (especially type C) in Taiwan
 [1], as 
well as in the whole of Asia [2], ends with the development of hepatocellular carcinoma, usually in a 
fibrotic  or  cirrhotic  liver.  ESC  (6,7-dihydroxy-2H-1-benzopyran-2-one;  ESC),  one  of  the  potent 
coumarin-derived  antioxidants,  reduces  oxidative  stress  in  various  modes  such  as  reduction  of 
neutrophil-dependent superoxide anion generation [3], free radical scavenging [4,5] and reduction of 
lipid  peroxidation  [6]. ESC  has  been  shown  to  have  an anti-inflammatory  effects  in  vivo [7]  and  
anti-proliferative effects on vascular smooth muscle cells [8]. Furthermore, ESC has been reported to 
inhibit oxidative damage induced by tert-butyl hydroperoxide in rat liver [9]. It has been isolated from 
various plants such as Artemisia capillaries, Citru slimonia and Euphorbia lathyris. In our preliminary 
study, ESC was demonstrated to inhibit CCl4-induced acute liver injury in rats. However, there is still 
little information on the effect of ESC on CCl4-induced fibrosis in rats. 
Carbon tetrachloride (CCl4) is extensively used to induce lipid peroxidation and toxicity. CCl4 is 
metabolized by cytochrome P450 2E1 to the trichloromethyl radical (CCl3
−), which is assumed to 
initiate free radical-mediated lipid peroxidation leading to the accumulation of lipid-derived oxidation 
products that cause liver injury [10]. Polyunsaturated fatty acids (PUFAs) in membrane lipids are 
especially  susceptible  to  free  radical-initiated  peroxidation.  PUFAs  in  phospholipids  of  the 
endothelium reticulum were decreased following CCl4 administration in vivo [11]. Liver fibrosis as 
well as the end-stage of liver fibrosis and cirrhosis represents the final common pathway of virtually 
all chronic liver diseases [12]. Its progression leads to cirrhosis and liver cancer [13].  
A number of investigators have previously demonstrated that antioxidants prevent CCl4 toxicity, 
particularly  hepatotoxicity,  by  inhibiting  lipid  peroxidation
  [14]  and  increasing  the  activities  of 
antioxidant enzymes [15]. Silymarin is a group of flavones extracted from Silubum marianum L and is 
a strong anti-oxidant [16] and an effective agent for liver protection and liver cell regeneration.  
Apoptosis is a genetically encoded form of cell suicide central to the development and homeostasis 
of multicellular organisms [17,18]. Researchers once assumed that the activation of endonucleases and 
specific proteases (such as caspases) reflect the key mechanism of apoptosis [19]. The mitochondrial 
pathway is partly dependent on the release of cytochrome c. After release from mitochondria to the 
cytosol, cytochrome c binds to apoptosis-activating factor-1 (Apaf-1), ATP (or dATP), and possibly a Int. J. Mol. Sci. 2011, 12                       
 
 
4055 
cytosolic protein (Apaf-3), and activates caspase 9, which in turn stimulates caspase 3 activity [20,21]. 
Bcl-2 proteins act on mitochondria to regulate apoptosis. The Bcl-2 family consists of both cell death 
promoters and preventers, including the anti-apoptotic proteins Bcl-2, Bcl- xL, Mcl-1, A1/Bfl-1 and 
Bcl-W, and the pro-apoptotic members Bax, Bak, Bad, Bik, Bid, Hrk and Bok [22]. Bcl-2 and Bcl-xL 
prevent  cytochrome  c  from  entering  the  cytosol,  either  by  blocking  release  or  binding  to  the 
cytochrome in a direct or indirect fashion, and consequently inhibiting activation of the downstream 
caspase  cascade.  Reactive  oxygen  species  (ROS),  which  induce  the  onset  of  the  mitochondrial 
permeability transition (MPT), play an important role in mitochondrial apoptosis. Activation of MPT is 
a major controlling mechanism in some apoptotic systems, and it also contributes to the release of 
cytochrome c and other apoptogenic proteins [20]. 
In the present study, we examined the effect of ESC on CCl4-induced liver apoptosis in rats. The 
hepatoprotective  effect  of  ESC  was  judged  by  histological  and  biochemical  values  including  the 
activities  of  serum  aspartate  amino  transferase  (sAST),  serum  alanine  amino  transferase  (sALT), 
superoxide  dismutase  (SOD),  glutathione  peroxidase  (GPx)  and  catalase  in  the  liver.  We  also 
examined  the  effects  of  ESC  on  the  regulation  of  the  proteins  in  the  Mitochondrial-Dependent 
Apoptotic Pathway in CCl4-induced liver apoptosis. In this study, silymarin was used as a positive  
control drug. 
2. Results and Discussion 
2.1. Serum ALT and AST Activities 
The  serum  activities  of  ALT  and  AST  were  significantly  elevated  in  the  CCl4-treated  
group (p < 0.001) where ESC (100 and 500 mg/kg BW) significantly decreased the activities of serum 
ALT and AST (p < 0.001). The effect of supplement of silymarin was similar to that observed for the 
ESC-treated group (p < 0.001) (Figure 1). 
Serum  levels  of  ALT  and  AST  are  the  most  commonly  used  biochemical  markers  of  liver  
injury [23]. Hepatic damage such as liver fibrosis, cirrhosis and liver atrophy can initiate the actions of 
regeneration,  and  thus  increase  the  weight  of  liver
  [24].  In  this  study,  it  is  shown  that  chronic 
administration of CCl4 led to a marked increase in ALT and AST levels. In addition, when liver injury 
was evaluated by a histological approach [25], infiltration of mononuclear cells around the Glisson’s 
sheath after 8 weeks of CCl4 treatment was detected. Furthermore, CCl4 was also found to cause a 
variety of histological changes in the liver, including centrizonal necrosis, portal inflammation, and 
Kupffer cell hyperplasia. These histological changes as well as the increase in hepatic enzymes were 
significantly attenuated by ESC (100 and 500 mg/kg/BW) (Table 1). Int. J. Mol. Sci. 2011, 12                       
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Figure 1. Effect of esculetin and silymarin on serum (A) alanine aminotransferase (ALT) 
and (B) aspartate aminotransferase (AST) levels in CCl4-treated rats. Data are expressed as 
mean  ±  SD  (n  = 10). *** p  <  0.001,  **  p <  0.01 as compared  with  the  CCl4  group.  
### p < 0.001 as compared with the Control group. Statistical analysis was carried out by 
one-way analysis of variance followed by Scheffe’s multiple range tests. 
 
 
 
Table 1. Effect of Esculetin and Silymarin on liver catalase, superoxide dismutase (SOD) 
and glutathione peroxidase (GPx) activities in CCl4-treated rats. 
Groups 
Activity (U/mg protein) 
Catalase  SOD  GPx 
Control  55.82 ±  0.3184  47.26 ±  0.77  64.12 ±  0.72 
CCl4   28.9 ±  0.484
###  24.84 ±  0.36
###  24.94 ±  0.46
### 
CCl4 + Silymarin200 mg/kg  33.74 ±  0.47
***  31.38 ±  0.71
***  30.42 ±  0.81
*** 
CCl4 + Esculetin 10 mg/kg  37.76 ±  0.79
*  27.4 ±  0.46  28.1 ±  0.55 
Cl4 + Esculetin 100 mg/g   38.13 ±  1.65
*  32.62 ±  0.724
***  36.06 ±  0.73
*** 
CCl4 + Esculetin 500 mg/kg  41.16 ±  0.64
***  32.8 ±  0.55
***  40.18 ±  0.44
*** 
Data are expressed as mean ±  SEM (n = 10). *p < 0.05, *** p < 0.001 as compared with the CCl4 group;  
### p < 0.001 as compared with the Control group. Int. J. Mol. Sci. 2011, 12                       
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2.2. Changes in Liver Histopathology 
As shown in Figure 2, normal hepatic architecture with a central vein and radiating hepatic cords 
were seen. In the CCl4-treated group, sections showed degeneration and necrosis, fibrosis, hepatocyte 
infiltration  containing  neutrophils  and  mononuclear  cells.  In  addition,  central-to-central  bridging 
necrosis was also noted. Moreover, treatment with of ESC (100 and 500 mg/kg BW) or silymarin 
significantly decreased the degree of inflammation, necrosis and fibrosis in CCl4-treated groups rats. 
Figure  2.  Photomicrographs  of  liver  sections  taken  from  rat  with  CCl4-induced  liver 
damage  after  pretreatment  with  esculetin  or  silymarin  for  8  weeks.  Liver  damage  was 
characterized by fatty degeneration, cell necrosis and mitosis. (Hematoxylin/Eosin staining, 
200× ) by Knodell et al. [25]. 
 
 
2.3. Hepatic Catalase, SOD and GPx Activities 
We next explored the effect of ESC on catalase, SOD and GPx activities in CCl4-induced hepatic 
fibrosis rats. It was found that the activities of SOD, GPx and catalase were markedly increased in rats 
treated with ESC (100 and 500 mg/kg BW). Hepatic GPx activities were significantly increased in rats 
treated with ESC (100 and 500 mg/kg BW) and silymarin (200 mg/kg BW) (P < 0.001) (Table 1). 
Living tissue is a major defense mechanism involving anti-oxidative enzymes that convert active 
oxygen molecules into non-toxic compounds [26,27]. Anti-oxidative enzymes, such as SOD, GPx and 
catalase,  are  easily  inactivated  by  lipid  peroxides  or  reactive  oxygen  species  during  CCl4  
exposure [28]. Glutathione (GSH) is a known radical scavenger, and GSH-related enzymes, such as 
GPx and GR, play detoxifying and anti-oxidative roles through conjugation with glutathione or free 
radical reduction [29].There are three classes of enzymes known to provide protection against reactive 
oxygen  species:  SOD,  catalase,  and  GPx  [30].  We  have  demonstrated  that  ESC  (100  and  Int. J. Mol. Sci. 2011, 12                       
 
 
4058 
500  mg/kg/BW)  significantly  reversed  the  CCl4-induced  decrease  in  activities  of  anti-oxidative 
enzymes, such as Catalase, SOD and GPx. These results suggested that ESC reduced CCl4-induced 
hepatic fibrosis in rats, probably by exerting a protective effect against hepatocellular fibrosis with its 
free-radical scavenging ability. 
2.4. Changes in Caspase-9, Caspase-3 and Cytochrome c Protein Levels in CCl4 -Treated Rats 
To  further  investigate  the  downstream  signal  components  of  cytochrome  c  release  in  the 
mitochondrial-dependent  signaling  pathway,  pro-caspase-9  levels,  activated  caspase-9,  pro-caspase-3 
levels and activated caspase-3 were measured by Western blotting. Compared with the control group, it 
was found that the activated caspase-3, activated caspase-9, and cytochrome c levels were significantly 
increased in the CCl4-treated group. In addition, the activated-caspase-9 levels and activated-caspase-3 
levels were significantly decreased in ESC-treated groups (100 and 500 mg/kg) (Figure 3). 
Carbon tetrachloride is a common hepatotoxin used in liver injury research. Early studies showed 
that the damage induced by CCl4 in liver is partly involved in the apoptosis pathway in vivo. At least 2 
different apoptosis pathways—the Mitochondrial pathway and the Death-receptor pathway—lead to 
caspase  activation  [31].  Although  past  reports  have  disclosed  caspase  3  activation  and  other 
histopathological  changes  in  CCl4-induced  apoptotic  hepatocytes  [32,33],  little  is  known  about  the 
precise molecular mechanisms of apoptosis induction. Cytochrome c release will form a complex with 
pro-caspase-9 and its cofactor Apaf-1 (apoptotic protease-activating factor-1). Therefore, it is responsible 
for activating caspase-9, which further activates caspase-3 and executes the apoptotic program. 
Figure  3.  (A) CCl4 chronic treated rats (for 8 weeks) were harvested and lysed. Total 
protein  of  cell  extracts  was  separated  by  12%  SDS-PAGE,  transferred  to  PVDF 
membranes,  and  immunoblotted  with  antibodies  against  proteins  as  indicated.  Equal 
loading  was  assessed  with  an  anti-tubulin  antibody.  Proteins  (pro-caspase-9,  
active-caspase-9 and pro-caspase-3, active-caspase-3, and cytochrome c) extracted from 
liver tissue were measured by Western blotting analysis. Equal loading was assessed with 
an  anti-α-tubulin  antibody.  (B)  The  expression  of  cytochrome  c,  active-caspase-3  and 
active-caspase-9  proteins.  *  p  <  0.05,  **  p  <  0.01  as  compared  with  the  CCl4  group; 
# p < 0.05 as compared with the Control group. 
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Figure 3. Cont. 
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2.5. Changes in Bcl-2 Family Components in CCl4-Treated Rats 
To further understand the effect of ESC on the mitochondrial-dependent apoptotic pathway, we 
examined  the  levels  of  three  pro-apoptotic  proteins  (Bak,  t-Bid,  and  Bax)  in  the  liver  tissue  of  
the CCl4-treated group. Bak, t-Bid and Bax levels in the CCl4-treated group were significantly higher 
than  those  in  the  control  group.  Also,  Bak,  t-Bid  and  Bax  levels  were  significantly  decreased  in  
the ESC-treated groups (100 and 500 mg/kg) (Figure 4). 
Figure 4. CCl4 chronic treated rats (for 8 weeks) were harvested and lysed. Total protein of 
cell  extracts was separated by 12%  SDS-PAGE, transferred to  PVDF  membranes,  and 
immunoblotted with antibodies against proteins as indicated. Equal loading was assessed 
with an anti-α-tubulin antibody. (A) Proteins (Bad, t-Bid, and Bax) extracted from liver 
tissue were measured by Western blotting analysis. Equal loading was assessed with an 
anti-α-tubulin antibody; (B) The expression of Bak, Bax and t-Bid proteins. *p < 0.05,  
** p < 0.01 as compared with the CCl4 group; #p < 0.05, ##p < 0.01 as compared with the 
Control group. 
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Figure 4. Cont. 
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We examined the levels of three anti-apoptotic Bcl-2 proteins, namely Bcl-2, p-Bad and Bcl-xL, in 
liver tissue of apoptosis rats. Bcl-2 and Bcl-x L levels were significantly lower in the CCl4-treated 
group than those in the control group. Bcl-xL and Bcl-2, but not p-Bad, were significantly increased in 
ESC-treated groups (100 and 500 mg/kg) (Figure 5). 
Figure 5. CCl4 chronic treated rats (for 8 weeks) were harvested and lysed. Total protein of 
cell  extracts was separated by 12%  SDS-PAGE, transferred to  PVDF  membranes,  and 
immunoblotted with antibodies against proteins as indicated. Equal loading was assessed 
with an anti-tubulin antibody. (A) The protein products of anti-apoptotic Bcl-2, Bcl-x L,  
p-Bad. Proteins extracted from liver tissue were measured by Western blotting analysis. 
Equal loading was assessed with an anti-tubulin antibody; (B) The expression of Bcl-2 and 
Bcl- x L proteins. ** p < 0.01 , *** p < 0.001as compared with the CCl4 group; # p < 0.05 , 
## p < 0.01 as compared with the Control group. 
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Figure 5. Cont. 
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Mitochondria  are  known  to  be  a  vulnerable  target  of  various  toxins  and  oxidative  stress.  The 
mitochondrial apoptotic pathway is regulated by the Bcl-2 family of proteins, which consist of both 
anti-apoptotic  (such  as  Bcl-2)  and  pro-apoptotic  (such  as  Bax)  proteins  [34].  Activation  of  the  
pro-apoptotic Bcl-2 family of proteins such as Bax is known to play an important role in the oxidative 
stress-induced apoptotic pathway [35]. It has been shown that Bax can translocate from the cytosol to 
mitochondria and exhibit conformational change under the apoptotic process. 
In this study, we have also demonstrated that ESC increased the levels of Bcl-2 and Bcl-x L and 
decreased the levels of Bak, Bax, t-Bid, cytochrome c, activated caspase-9, and activated caspase-3 
proteins in rats exposed to CCl4. Our data show that Bax protein content markedly increased in rats 
receiving CCl4 alone, suggesting that oxidative stress caused by CCl4 administration has activated Bax, 
Bak and t-Bid. We also found that Bcl-2 protein content markedly increased in rats receiving CCl4 
alone. Administration of ESC effectively decreased the levels of Bak, Bax, and t-Bid.  
In  summary,  mitochondria-initiated  apoptosis  triggered  by  ROS  plays  an  important  role  in  
CCl4-induced hepatotoxicity in rats. ESC significantly reduced CCl4-induced hepatic fibrosis in rats, 
probably by exerting a protective effect against hepatocellular fibrosis with its free-radical scavenging 
ability and inhibiting the Mitochondrial-Dependent Apoptotic Pathway in CCl4-induced liver apoptosis 
in rats (Figure 6). 
(B) Int. J. Mol. Sci. 2011, 12                       
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Figure  6.  Proposed  mechanisms  of  action  of  esculetin  on  liver  apoptosis.  Esculetin 
suppresses  the  mitochondrial-dependent  apoptotic  pathway  by  inhibiting  the  release  of 
mitochondrial pro-apoptotic proteins Bax, Bak, and t-Bid which in turn inhibits the release 
of cytochrome c, caspase-9 and caspase 3, there by inducing the release of anti-apoptotic 
proteins Bcl-2 and Bcl-x L. 
 
3. Experimental Section 
3.1. Animals 
Male  Sprague-Dawley  rats  were  obtained  from  the  BioLASCO  Taiwan  Co.,  Ltd.,  and  fed  with  a 
standard  laboratory  diet  and  tap  water  ad  libitum.  The  experimental  animals  were  housed  in  an  
air-conditioned room of 22 ±  1 °C  and 12 h of light. The rats were allowed free access to powdered feed, 
and mains water that was supplied through an automatic watering system. When they reached 250–300 g, 
the rats were used for experiments. Rats were divided randomly into groups according to the body 
weight in a proper range one day before administration of the test substance. All experimental procedures 
were  performed  according  to  the  NIH  Guide  for  the  Care  and  Use  of  Laboratory  Animals.  The 
experimental protocol was approved by the Committee on Animal Research, China Medical University. 
3.2. CCl4-Induced Liver Apoptosis 
Apoptosis was induced in five groups of 10 rats by an oral administration of 0.5 mL/rat CCl4, 
diluted 1:5 (v/v) in olive oil, twice a week for 8 weeks. The animals received only CCl4, CCl4 with 
ESC  (10,  100  and  500  mg/kg  BW,  po,  daily)  or  silymarin  (Sigma-Aldrich,  Steinheim,  Germany;  Int. J. Mol. Sci. 2011, 12                       
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200 mg/kg BW, daily). The ESC and silymarin were given when the CCl4-induced chronic injury 
model started, and the total drug treatment duration was 8 weeks. 
After the blood was drawn from rats at the eighth week, the animals were sacrificed at the same 
time and the livers were quickly taken out. They were then weighed after being clearly washed with 
cold normal saline and the moisture sucked up. The largest lobe of liver was divided into two parts for 
each liver sample, one part was submerged in 10% neutral formalin for the preparation of pathological 
section, and the other part was stored as a reserve at −80 °C .  
3.3. Assessment of Liver Functions 
The blood was centrifuged  at 3024 g (BACKMAN,  Krefeld, Germany)  at 4 ° C for 15 min  to 
separate  serum.  The  levels  of  serum  Alanine  Aminotransferase  (sALT)  and  serum  Aspartate 
Aminotransferase  (sAST)  were  assayed  using  clinical  test  kits  (Roche,  Berlin,  Germany) 
spectrophotometrically (Cobas Mira Plus, Frankfurt, Germany). 
3.4. Antioxidant Enzymes Activity Measurements 
Livers were homogenized in nine volumes of isotonic phosphate buffer (0.01 M, pH 7.0). The 
prepared liver homogenate was centrifuged at 700 g for 5 min at 4  °C . Catalase was assayed by 
measuring the destruction of H2O2 at 240 nm according to the method of Aebi [36]. One unit (U) of 
this enzyme activity is defined as the amount of the enzyme giving K
−1; where K is the rate constant of 
the enzyme. Activity is expressed as U per mg of protein (U/mg protein). Superoxide dismutase (SOD) 
activity was determined according to the method of Misra and Fridovich
 [37] at room temperature. One 
hundred microliters of tissue extract was added to 880 μL (pH 10.2, 0.1 mM EDTA) carbonate buffer. 
Twenty  microliters  of  30  mM  epinephrine  (in  0.05%  acetic  acid)  was  added  to  the  mixture  and 
measured  at  480  nm  for  4  min  on  a  Jassco  V-550  Spectrophotometer.  The  enzyme  activity  was 
expressed as the amount of enzyme that inhibits the oxidation of epinephrine by 50%, which is equal 
to 1 unit. 
Glutathione  peroxidase  (GPx)  activity  was  determined  according  to  the  method  of  Flohe  and 
Gunzler [38] at 37 °C. A reaction mixture was composed of 500 μL phosphate buffer, 100 μL 0.01 M 
GSH (reduced form), 100 μL 1.5 mM NADPH and 100 μL GRx (0.24 units). One hundred microliters 
of the tissue extract was added to the reaction mixture and incubated at 37 °C for 10 min. Then 50 μL 
of 12 mM t-butyl hydroperoxide was added to 450 μL tissue reaction mixture and measured at 340 nm 
for 180 s. The molar extinction coefficient of 6.22 ×  10
−3 M
−1 cm
−1 was used to determine the enzyme 
activity. One unit of activity is equal to the mM of NADPH oxidized/min per mg protein. 
3.5. Pathological Examinations 
For  histopathological  examination,  the  formalin  fixed  liver  was  embedded  in  paraffin,  cut  into  
4–5 mm thick sections, stained with hematoxylin-eosin, and observed under a photomicroscope. Int. J. Mol. Sci. 2011, 12                       
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3.6. Assessment of Liver Apoptosis Proteins and Anti-Apoptic Proteins 
Liver tissue was homogenated in PBS buffer at a ratio of 100 mg tissue/0.5 mL PBS for 5 min. The 
homogenates were placed on ice for 10 min and then centrifuged at 12,000 g for 30 min. Samples 
containing equal proteins (40 g) were loaded and analyzed by Western blot analysis. Briefly, proteins 
were separated by 12% SDS-PAGE and transferred onto PVDF membranes (Millipore, Belford, NJ, 
USA).  Membranes  were  blocked  with  blocking
  buffer  (5%  non-fat  dry  milk,  20 mM  Tris-HCl,  
pH 7.6, 150 mM NaCl, and 0.1%
 Tween 20) for at least 1 h at room temperature and then incubated 
with primary antibodies in the above solution on an orbit shaker at 4 ° C overnight. Following primary 
antibody  incubations,  membranes  were  incubated  with  horseradish  peroxidase-linked  secondary 
antibodies (anti-rabbit, anti-mouse, or anti-goat IgG). 
3.7. Statistical Analysis 
Data were expressed as mean ±  SEM. Statistical evaluation was carried out by one-way analysis of 
variance (One-way ANOVA) followed by Scheffe’s multiple range tests. P values of less than 0.05 
were considered significantly. 
4. Conclusions 
The  present  study  demonstrated  that  CCl4 induced  a  marked  rise  in  oxidative  stress.  Our  data 
suggested  that  mitochondria-initiated  apoptosis  triggered  by  ROS  plays  an  important  role  in  
CCl4-induced hepatotoxicity rats. ESC significantly reduced CCl4-induced hepatic apoptosis in rats, 
probably  by  exerting  a  protective  effect  against  hepatocellular  apoptosis  with  its  free-radical 
scavenging ability and inhibiting the Mitochondrial-Dependent Apoptotic Pathway in CCl4-induced 
liver apoptosis in rats. 
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